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Introduction
• Creatine is a naturally occurring compound composed of three amino 
acids: glycine, arginine, and methionine. (Kreider et al. 2017)
• Approximately 95% of creatine is found within skeletal muscle, with 
the remainder being found in the brain and testes (in males). 
• Creatine supplementation increases muscle phosphocreatine 
concentration, reduces muscle acidosis and oxidative metabolism, and 
increases lean body mass. 
• Creatine has been extensively studied for its use as an ergogenic aid in 
athletes of all sports, particularly those involving short bursts of 
activity. 
Applicability to Clinical Practice
Discussion
Depression
• Has shown potential to improve depression symptoms when used in 
conjunction with SSRIs.
• May make onset of efficacy faster for SSRIs.
• Should be avoided with bipolar depression due to risk of inducing 
manic episodes.
Diabetes
• Improved glycemic control, especially when paired with exercise, 
due to increase in GLUT-4 membrane content.
• Does not impair kidney function in patients with T2DM.
Osteoarthritis
• Increased lean mass, muscle strength, and physical function.
• Combined with exercise, may stop or reduce progress of 
osteoarthritis.
Safety
• Only potential side effect is mild weight gain due to increases in 
lean mass. Studies going as long as five years and with doses up to 
30g/day identify no other adverse effects.
• Has been studied in infants, adolescents, adults, and pregnancy with 
no evidence of additional side effects.
Abstract
The purpose of this study was to determine whether supplementation 
with creatine monohydrate is efficacious beyond the realm of its most 
popular use, which is in athletics. This study investigated the safety of 
creatine supplementation in the general population. References were 
collected through a review of PubMed and Scopus databases. Initial 
keywords searched were creatine supplementation and creatine safety. 
Where possible, trials with human subjects were utilized. Studies focused 
on creatine’s effects in athletes or weightlifting parameters were 
eliminated. Topics were further narrowed down by conditions with the 
most amount of research and medical concerns recognized as common to 
primary care. Creatine supplementation showed potential benefits in 
treatment for major depressive disorder, diabetes, bone density, and 
osteoarthritis. Mild weight gain due to the osmotic effect of creatine was 
the only side effect noted in the evidence. Kidney function is not affected 
by creatine supplementation. Creatine supplementation has potential 
benefits for many different patient populations, with the only side effect 
of creatine supplementation being mild weight gain due to the osmotic 
effect of increased creatine saturation in the body. Clinicians should 
consider creatine supplementation without fear of potential serious 
adverse effects based on the available evidence.
Literature Review
A search of the literature showed creatine has been studied for multiple 
common disease processes including depression, type 2 diabetes 
mellitus, and osteoarthritis.
Depression
• Lyoo et al. (2012) found that adding creatine to escitalopram resulted 
in a earlier treatment response compared to escitalopram and placebo.
• Creatine should be avoided in bipolar depression due to its possibility 
of inducing mania (Toniolo, Fernandes, Silva, da Silva Dias, and 
Lafer 2016).
Diabetes
• Gualano et al. (2011a) reported 5g creatine/day combined with 
exercise lowered HbA1c by 1.1% compared to no change in the 
control group. These same participants showed no change in their 
kidney function after 12 weeks of creatine use (Gualano et al. 2011b).
• Alves et al. (2012) found creatine supplementation increased presence 
GLUT-4 receptors, which explains one of the mechanisms by which 
creatine helps regulate glycemic control.
Osteoarthritis
• Neves et al. (2011) studied creatine supplementation in patients with 
knee osteoarthritis. The creatine group showed improved quality of 
life and decreased pain compared to the placebo group.
Safety
• A review of over 1,000 creatine studies (Kreider et al. 2017) showed 
no evidence of any adverse effects of creatine supplementation up to 
30g/day and/or 5 years.
• The only consistent effect noted was mild lean mass gain, primarily 
due to the osmotic effect of creatine.
• Creatine has been shown to be safe in age ranges from infant to 
geriatric, and even in pregnancy. 
• Depression, diabetes, and osteoarthritis are common diseases 
encountered by all primary care practitioners.
• Creatine has numerous reported benefits and very few adverse affects. 
This makes creatine a possible adjunctive therapy for treatment of 
these diseases. 
• Clinicians should consider trialing creatine therapy, especially if 
traditional treatment options are failing to provide adequate response.
• Further large scale trials showing benefits of creatine will be needed 
before creatine becomes a more widely accepted treatment option.
• Based on the current studies, clinicians should NOT discourage 
patients from creatine use if asked about its safety.
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Research Questions
• Does creatine supplementation provide benefit in any patient 
populations besides athletes? 
• Is creatine supplementation safe?
Statement of the Problem
Creatine is used by athletes worldwide; however, creatine has also been 
studied for numerous other potential benefits in both general and disease-
specific populations. These results are not nearly as well known, and 
creatine is not widely used outside of the athlete population. Clinicians 
may be missing opportunities to utilize creatine, which is a cheap, over-
the-counter nutritional aid. Additionally, there is often concern voiced 
over the safety of creatine supplementation, often citing deleterious 
effects on hydration, kidney function, or overall health. These concerns 
may not be founded in actual scientific evidence.
Effects of creatine supplementation combined with exercise training in type 2 diabetic patients on HbA1c concentrations. *Interaction 
effect (P = 0.004; estimated difference of means = -1.1%, 95% CI= -1.9% to -0.4%). Graph courtesy of Gualano, B., de Salles Painneli, 
V., Roschel, H., Artioli, G. G., Neves, M. J., De Sá Pinto, Ana Lúcia, . . . Lancha, A. H. J. (2011a). Creatine in type 2 diabetes: A 
randomized, double-blind, placebo-controlled trial. Medicine & Science in Sports & Exercise, 43(5), 770–778. 
http://dx.doi.org/10.1249/MSS.0b013e3181fcee7d
Percentage Change in Hamilton Depression Rating Scale (HAM-D) Score for Women With Major Depressive Disorder Assigned to 
Creatine Monohydrate or Placebo Augmentation of SSRIaa Mean changes in total score with 95% confidence intervals are shown. 
b Significant difference between groups in intent-to-treat analysis (p<0.001). Graph courtesy of Lyoo, I. K., Yoon, S., Kim, T., Hwang, 
J., Kim, J. E., Won, W., . . . Renshaw, P. F. (2012). A randomized, double-blind placebo-controlled trial of oral creatine monohydrate 
augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder. The American 
Journal of Psychiatry, 169(9), 937. http://dx.doi.org/10.1176/appi.ajp.2012.12010009
Glomerular filtration rate (ml/min) calculated from plasma Cystatin-C determination among young athletes with no creatine 
supplementation (control) and individuals who regularly, several days per week, ingested exogenous creatine during less than a year to 
several years. All values are within the normal range for a clinically normal population. The number (n) of young individuals (mean age: 
14–28 years), the daily quantity per day (g/day) and the number of days per week (day/week) of creatine supplementation are given for 
each category. Graph courtesy of Kim, H., Kim, C., Carpentier, A., & Poortmans, J. (2011). Studies on the safety of creatine 
supplementation.Amino Acids, 40(5), 1409-1418. http://dx.doi.org/10.1007/s00726-011-0878-2
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